Tumor hypoxia on 18F-fluoromisonidazole (FMISO) positron emission tomography (PET) may serve as a reliable clinical biomarker of distant metastasis risk for patients with head and neck squamous cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback